home / stock / nvno / nvno message board
Subject | By | Source | When |
---|---|---|---|
enVVeno Medical Reports Third Quarter 2021 Financial Results | conix | investorshub | 11/11/2021 2:09:57 PM |
$NVNO Chart | conix | investorshub | 11/05/2021 7:39:31 PM |
enVVeno Medical Reports Successful Completion of First VenoValve | conix | investorshub | 10/22/2021 1:35:38 PM |
znewcar1: HJLI 41% v19,5M c11.54 f2,2M H17.68 then a fast pwr hour down S10 | znewcar1 | investorshangout | 12/11/2020 10:59:38 PM |
znewcar1: HJLI 37% v8,1M c.5638 f38,3M H.58 bounced off the 30dma | znewcar1 | investorshangout | 09/11/2020 8:17:49 PM |
znewcar1: HJLI 63% v461M c.4602 f38,3M H.81 morning pop hit .625 back to .45 then push to HOD | znewcar1 | investorshangout | 08/21/2020 8:21:18 PM |
News, Short Squeeze, Breakout and More Instantly...
enVVeno Medical Corp Com Company Name:
NVNO Stock Symbol:
NASDAQ Market:
Live video webcast with Robert Berman, Chief Executive Officer of enVVeno Medical on Thursday, June 27 th at 4:00 PM ET IRVINE, CA / ACCESSWIRE / June 25, 2024 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatmen...
91% of Venous Ulcer Patients Evaluated at One Year Have Either Fully Healed Ulcers or Ulcers That Have Improved 100% of Venous Ulcers with a Duration of One Year or Less Prior to VenoValve Surgery Have Fully Healed 89% of Venous Ulcers with a Duration of More Than One Year Prior to Veno...
IRVINE, CA / ACCESSWIRE / June 17, 2024 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, today announced that new interim venous ulcer healing data from the VenoValve U.S. pivotal trial will be ...